Two funds, two fundraising rhythms
Sheridan's fundraising success contains two different stories. Sheridan Capital Partners Fund IV closed at $1.1 billion, above its $800 million target, and The Wall Street Journal reported that it was raised in roughly 60 days. That speed suggests institutional investors remain willing to move quickly when they have confidence in a sector specialist with a record in an area such as healthcare, where underlying demand is viewed as comparatively resilient.
Sheridan Healthcare IT Fund I, by contrast, closed at $245 million after more than a year in market. The slower process reflects a newer layer of investor caution. Backers still see attractive prospects in health software, but they are asking harder questions about whether artificial intelligence will change product economics, development costs or the competitive position of traditional software businesses. The differing timelines therefore offer a useful snapshot of today's private-capital risk appetite.
Why healthcare remains attractive
Sheridan argues that healthcare benefits from durable structural forces: ageing populations, rising utilization, increasing administrative complexity and a fragmented provider landscape that still has room for consolidation. On its website, the firm emphasizes a healthcare-only approach and targets U.S.
















